A sufficient intake of vitamin D may prevent or delay the onset of diabetes, concluded research from Loyola University Chicago, Marcella Niehoff School of Nursing.
A sufficient intake of vitamin D may prevent or delay the onset of diabetes, concluded research from Loyola University Chicago, Marcella Niehoff School of Nursing. The study, appearing in the latest issue of Diabetes Educator, said adequate intake may also reduce complications for those who have already been diagnosed with diabetes.
"Vitamin D has widespread benefits for our health and certain chronic diseases in particular," said study co-author, Sue Penckofer, PhD, RN. "This article further substantiates the role of this nutrient in the prevention and management of glucose intolerance and diabetes."
One study examined for the review article evaluated 3,000 people with type 1 diabetes and found a decreased risk in disease for people who took vitamin D supplements. Observational studies of people with type 2 diabetes also revealed that supplementation may be important in the prevention of this disease.
"Management of vitamin D deficiency may be a simple and cost-effective method to improve blood sugar control and prevent the serious complications associated with diabetes," said study co-author, Joanne Kouba, PhD, RD, LDN.
Diet alone may not be sufficient to manage vitamin D levels. A combination of adequate dietary intake of vitamin D, exposure to sunlight, and treatment with vitamin D2 or D3 supplements can decrease the risk of diabetes and related health concerns. The preferred range in the body is 30 - 60 ng/mL of 25(OH) vitamin D.
An estimated 23 million Americans with diabetes have low vitamin D levels. Vitamin D deficiency may also be associated with hyperglycemia, insulin resistance, hypertension and heart disease.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.